SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2022 |
| Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
| Texto Completo: | https://www.arca.fiocruz.br/handle/icict/56355 |
Resumo: | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). Todos pela Saúde do Itaú Unibanco. Wellcome Trust and Royal Society Sir Henry Dale Fellowship. Fundação Gates. UK Medical Research Council. Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Fundação Faculdade de Medicina Programa Inova Fiocruz-CE/Funcap. |
| id |
CRUZ_797e83bd558ffcf1c895e94162cd9678 |
|---|---|
| oai_identifier_str |
oai:www.arca.fiocruz.br:icict/56355 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Prete Jr, Carlos A.Buss, Lewis F.Whittaker, CharlesSalomon, TassilaOikawa, Marcio K.Pereira, Rafael H. M.Moura, Isabel C. G.Delerino, LucasBarral Netto, ManoelTavares, Natalia M.Franca, Rafael F. OBoaventura, Viviane S.Miyajima, FabioMendrone Junior, AlfredoAlmeida Neto, Cesar deSalles, Nanci A.Ferreira, Suzete C.Fladzinski, Karine A.Souza, Luana M. deSchier, Luciane K.Inoue, Patricia M.Xabregas, Lilyane A.Crispim, Myuki A. E.Fraiji, NelsonAraujo, Fernando L. V.Carlos, Luciana M. BPessoa, VeridianaRibeiro, Maisa A.Souza, Rosenvaldo E. deSilva, Sônia M. N. daCavalcante, Anna F.Valença, Maria I. BSilva, Maria V. daLopes, EstherMelo Filho, Luiz Amorim deMateos, Sheila O. G.Nunes, Gabrielle T.Silva Junior, Alexander L.Busch, Michael P.Castro, Marcia C.Dye, ChristopherRatmann, OliverFaria, Nuno R.Nascimento, Vítor H.Sabino, Ester C.2023-01-06T18:27:15Z2023-01-06T18:27:15Z2022PRETE JR, Carlos A. et al. SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study. eLife, v. 11, p. 1-53, 2022.2050-084Xhttps://www.arca.fiocruz.br/handle/icict/5635510.7554/eLife.78233.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). Todos pela Saúde do Itaú Unibanco. Wellcome Trust and Royal Society Sir Henry Dale Fellowship. Fundação Gates. UK Medical Research Council. Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Fundação Faculdade de Medicina Programa Inova Fiocruz-CE/Funcap.Universidade de São Paulo. Departamento de Engenharia de Sistemas Eletrônicos. São Paulo, SP, Brasil.Imperial College London. London, United Kingdom.MRC Centre for Global Infectious Disease Analysis. Imperial College London. London, United Kingdom / Abdul Latif Jameel Institute for Disease and Emergency Analytics. Imperial College London. London, United Kingdom.Faculdade Ciências Médicas de Minas Gerais. Belo Horizonte, MG, Brasil.Universidade Federal do ABC. São Bernardo do Campo, SP, Brasil.Instituto de Pesquisa Econômica Aplicada. Brasília, DF, Brasil.Faculdade Ciências Médicas de Minas Gerais. Belo Horizonte, MG, Brasil.Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil / Universidade Federal do Ceará. Fortaleza, CE, Brasil.Fundação Pró-sangue Hemocentro de São Paulo. São Paulo, SP, Brasil.Fundação Pró-sangue Hemocentro de São Paulo. São Paulo, SP, Brasil.Fundação Pró-sangue Hemocentro de São Paulo. São Paulo, SP, Brasil.Fundação Pró-sangue Hemocentro de São Paulo. São Paulo, SP, Brasil.Centro de Hematologia e Hemoterapia do Paraná. Curitiba, PR, Brasil.Centro de Hematologia e Hemoterapia do Paraná. Curitiba, PR, Brasil.Centro de Hematologia e Hemoterapia do Paraná. Curitiba, PR, Brasil.Centro de Hematologia e Hemoterapia do Paraná. Curitiba, PR, Brasil.Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas. Manaus, AM, Brasil.Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas. Manaus, AM, Brasil.Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas. Manaus, AM, Brasil.Fundação de Hematologia e Hemoterapia da Bahia. Salvador, BA, Brasil.Centro de Hematologia e Hemoterapia do Ceará. Fortaleza, CE, Brasil.Centro de Hematologia e Hemoterapia do Ceará. Fortaleza, CE, Brasil.Fundação HEMOMINAS. Belo Horizonte, MG, Brasil.Fundação HEMOMINAS. Belo Horizonte, MG, Brasil.Fundação HEMOMINAS. Belo Horizonte, MG, Brasil.Fundação de Hematologia e Hemoterapia de Pernambuco. Recife, PE, Brasil.Fundação de Hematologia e Hemoterapia de Pernambuco. Recife, PE, Brasil.Fundação de Hematologia e Hemoterapia de Pernambuco. Recife, PE, Brasil.Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti. Rio de Janeiro, RJ, Brasil.Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti. Rio de Janeiro, RJ, Brasil.Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil / Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti. Rio de Janeiro, RJ, BrasilFundação Hospitalar de Hematologia e Hemoterapia do Amazonas. Manaus, AM, Brasil / Universidade Federal do Amazonas. Manaus, AM, Brasil / Centro Universitário do Norte. Manaus, AM, Brasil.Vitalant Research Institute. San Francisco, United States / University of California. San Francisco, United States.Harvard TH Chan School of Public Health. Boston, United States.Department of Zoology. University of Oxford. Oxford, United Kingdom.Imperial College London. London, United Kingdom.Imperial College London. London, United Kingdom / MRC Centre for Global Infectious Disease Analysis. Imperial College London. London, United Kingdom / Department of Zoology. University of Oxford. Oxford, United Kingdom / Universidade de São Paulo. Instituto de Medicina Tropical. São Paulo, SP, Brasil.Universidade de São Paulo. Departamento de Engenharia de Sistemas Eletrônicos. São Paulo, SP, Brasil.Universidade de São Paulo. Instituto de Medicina Tropical. São Paulo, SP, Brasil.Background: The COVID-19 situation in Brazil is complex due to large differences in the shape and size of regional epidemics. Understanding these patterns is crucial to understand future outbreaks of SARS-CoV-2 or other respiratory pathogens in the country. Methods: We tested 97,950 blood donation samples for IgG antibodies from March 2020 to March 2021 in 8 of Brazil's most populous cities. Residential postal codes were used to obtain representative samples. Weekly age- and sex-specific seroprevalence were estimated by correcting the crude seroprevalence by test sensitivity, specificity, and antibody waning. Results: The inferred attack rate of SARS-CoV-2 in December 2020, before the Gamma variant of concern (VOC) was dominant, ranged from 19.3% (95% credible interval [CrI] 17.5-21.2%) in Curitiba to 75.0% (95% CrI 70.8-80.3%) in Manaus. Seroprevalence was consistently smaller in women and donors older than 55 years. The age-specific infection fatality rate (IFR) differed between cities and consistently increased with age. The infection hospitalisation rate increased significantly during the Gamma-dominated second wave in Manaus, suggesting increased morbidity of the Gamma VOC compared to previous variants circulating in Manaus. The higher disease penetrance associated with the health system's collapse increased the overall IFR by a minimum factor of 2.91 (95% CrI 2.43-3.53). Conclusions: These results highlight the utility of blood donor serosurveillance to track epidemic maturity and demonstrate demographic and spatial heterogeneity in SARS-CoV-2 spread.engeLife Sciences PublicationsCOVID-19SARS-CoV-2Taxa de ataqueDoadores de sangueEpidemiologiaSaúde globalTaxa de mortalidade por infecçãoSorovigilânciaVírusCOVID-19SARS-CoV-2Attack rateBlood donorsEpidemiologyGlobal healthInfection fatality rateSerosurveillanceVirusesCOVID-19SARS-CoV-2IncidênciaDoadores de SangueEpidemiologiaSaúde globalMortalidadeVírusSARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional studyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/56355/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALPrete, J. SARS-CoV-2 antibody dynamics.pdfPrete, J. SARS-CoV-2 antibody dynamics.pdfapplication/pdf21513752https://www.arca.fiocruz.br/bitstream/icict/56355/2/Prete%2c%20J.%20SARS-CoV-2%20antibody%20dynamics.pdf7b5a02a6714c96049d44366cc8bde05cMD52icict/563552023-03-15 14:32:49.859oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:32:49Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.en_US.fl_str_mv |
SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study |
| title |
SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study |
| spellingShingle |
SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study Prete Jr, Carlos A. COVID-19 SARS-CoV-2 Taxa de ataque Doadores de sangue Epidemiologia Saúde global Taxa de mortalidade por infecção Sorovigilância Vírus COVID-19 SARS-CoV-2 Attack rate Blood donors Epidemiology Global health Infection fatality rate Serosurveillance Viruses COVID-19 SARS-CoV-2 Incidência Doadores de Sangue Epidemiologia Saúde global Mortalidade Vírus |
| title_short |
SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study |
| title_full |
SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study |
| title_fullStr |
SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study |
| title_full_unstemmed |
SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study |
| title_sort |
SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study |
| author |
Prete Jr, Carlos A. |
| author_facet |
Prete Jr, Carlos A. Buss, Lewis F. Whittaker, Charles Salomon, Tassila Oikawa, Marcio K. Pereira, Rafael H. M. Moura, Isabel C. G. Delerino, Lucas Barral Netto, Manoel Tavares, Natalia M. Franca, Rafael F. O Boaventura, Viviane S. Miyajima, Fabio Mendrone Junior, Alfredo Almeida Neto, Cesar de Salles, Nanci A. Ferreira, Suzete C. Fladzinski, Karine A. Souza, Luana M. de Schier, Luciane K. Inoue, Patricia M. Xabregas, Lilyane A. Crispim, Myuki A. E. Fraiji, Nelson Araujo, Fernando L. V. Carlos, Luciana M. B Pessoa, Veridiana Ribeiro, Maisa A. Souza, Rosenvaldo E. de Silva, Sônia M. N. da Cavalcante, Anna F. Valença, Maria I. B Silva, Maria V. da Lopes, Esther Melo Filho, Luiz Amorim de Mateos, Sheila O. G. Nunes, Gabrielle T. Silva Junior, Alexander L. Busch, Michael P. Castro, Marcia C. Dye, Christopher Ratmann, Oliver Faria, Nuno R. Nascimento, Vítor H. Sabino, Ester C. |
| author_role |
author |
| author2 |
Buss, Lewis F. Whittaker, Charles Salomon, Tassila Oikawa, Marcio K. Pereira, Rafael H. M. Moura, Isabel C. G. Delerino, Lucas Barral Netto, Manoel Tavares, Natalia M. Franca, Rafael F. O Boaventura, Viviane S. Miyajima, Fabio Mendrone Junior, Alfredo Almeida Neto, Cesar de Salles, Nanci A. Ferreira, Suzete C. Fladzinski, Karine A. Souza, Luana M. de Schier, Luciane K. Inoue, Patricia M. Xabregas, Lilyane A. Crispim, Myuki A. E. Fraiji, Nelson Araujo, Fernando L. V. Carlos, Luciana M. B Pessoa, Veridiana Ribeiro, Maisa A. Souza, Rosenvaldo E. de Silva, Sônia M. N. da Cavalcante, Anna F. Valença, Maria I. B Silva, Maria V. da Lopes, Esther Melo Filho, Luiz Amorim de Mateos, Sheila O. G. Nunes, Gabrielle T. Silva Junior, Alexander L. Busch, Michael P. Castro, Marcia C. Dye, Christopher Ratmann, Oliver Faria, Nuno R. Nascimento, Vítor H. Sabino, Ester C. |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Prete Jr, Carlos A. Buss, Lewis F. Whittaker, Charles Salomon, Tassila Oikawa, Marcio K. Pereira, Rafael H. M. Moura, Isabel C. G. Delerino, Lucas Barral Netto, Manoel Tavares, Natalia M. Franca, Rafael F. O Boaventura, Viviane S. Miyajima, Fabio Mendrone Junior, Alfredo Almeida Neto, Cesar de Salles, Nanci A. Ferreira, Suzete C. Fladzinski, Karine A. Souza, Luana M. de Schier, Luciane K. Inoue, Patricia M. Xabregas, Lilyane A. Crispim, Myuki A. E. Fraiji, Nelson Araujo, Fernando L. V. Carlos, Luciana M. B Pessoa, Veridiana Ribeiro, Maisa A. Souza, Rosenvaldo E. de Silva, Sônia M. N. da Cavalcante, Anna F. Valença, Maria I. B Silva, Maria V. da Lopes, Esther Melo Filho, Luiz Amorim de Mateos, Sheila O. G. Nunes, Gabrielle T. Silva Junior, Alexander L. Busch, Michael P. Castro, Marcia C. Dye, Christopher Ratmann, Oliver Faria, Nuno R. Nascimento, Vítor H. Sabino, Ester C. |
| dc.subject.other.en_US.fl_str_mv |
COVID-19 SARS-CoV-2 Taxa de ataque Doadores de sangue Epidemiologia Saúde global Taxa de mortalidade por infecção Sorovigilância Vírus |
| topic |
COVID-19 SARS-CoV-2 Taxa de ataque Doadores de sangue Epidemiologia Saúde global Taxa de mortalidade por infecção Sorovigilância Vírus COVID-19 SARS-CoV-2 Attack rate Blood donors Epidemiology Global health Infection fatality rate Serosurveillance Viruses COVID-19 SARS-CoV-2 Incidência Doadores de Sangue Epidemiologia Saúde global Mortalidade Vírus |
| dc.subject.en.en_US.fl_str_mv |
COVID-19 SARS-CoV-2 Attack rate Blood donors Epidemiology Global health Infection fatality rate Serosurveillance Viruses |
| dc.subject.decs.en_US.fl_str_mv |
COVID-19 SARS-CoV-2 Incidência Doadores de Sangue Epidemiologia Saúde global Mortalidade Vírus |
| description |
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). Todos pela Saúde do Itaú Unibanco. Wellcome Trust and Royal Society Sir Henry Dale Fellowship. Fundação Gates. UK Medical Research Council. Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Fundação Faculdade de Medicina Programa Inova Fiocruz-CE/Funcap. |
| publishDate |
2022 |
| dc.date.issued.fl_str_mv |
2022 |
| dc.date.accessioned.fl_str_mv |
2023-01-06T18:27:15Z |
| dc.date.available.fl_str_mv |
2023-01-06T18:27:15Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
PRETE JR, Carlos A. et al. SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study. eLife, v. 11, p. 1-53, 2022. |
| dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/56355 |
| dc.identifier.issn.en_US.fl_str_mv |
2050-084X |
| dc.identifier.doi.none.fl_str_mv |
10.7554/eLife.78233. |
| identifier_str_mv |
PRETE JR, Carlos A. et al. SARS-CoV- 2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: a serial cross-sectional study. eLife, v. 11, p. 1-53, 2022. 2050-084X 10.7554/eLife.78233. |
| url |
https://www.arca.fiocruz.br/handle/icict/56355 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
eLife Sciences Publications |
| publisher.none.fl_str_mv |
eLife Sciences Publications |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/56355/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/56355/2/Prete%2c%20J.%20SARS-CoV-2%20antibody%20dynamics.pdf |
| bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 7b5a02a6714c96049d44366cc8bde05c |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1813008904835039232 |